Mark 0 Goodarzi MD

Diabetes, Lipid Metabolism

Physician

8700 Beverly Blvd.Los Angeles, CA 90048
Phone+1 310-423-4774
Fax+1 310-423-0440

Dr. Goodarzi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goodarzi's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2004
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1997 - 1999
University of California San Francisco School of MedicineClass of 1997
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Gastroenterology

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1998 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Publications & Presentations

PubMed

Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (...
Ningyuan Wang, Daniel A DiCorpo, Yixin Zhang, Erica Kleinbrink, Donna K Arnett
Diabetes. 2026-08-01
1 citations
Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis an...
Kathleen M Dungan, Vernon M Chinchilli, Ariana Pichardo-Lowden, Nazia Raja-Khan, Melena D Bellin
Diabetes Care. 2026-06-01
Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program.
Yixin Zhang, Ngoc Quynh H Nguyen, Paul A Hanson, Magdalena Sevilla-Gonzalez, Jeffrey Haessler
Atherosclerosis. 2026-06-01

Lectures

Novel Topics in Management of PCOS Patients
ENDO 2019 - New Orleans, LA - 3/26/2019

Press Mentions

Gene Expression in Early Pregnancy Could Contribute to Sex-Based Health DifferencesOctober 23rd, 2024
Gut Bacteria Could Influence the Development of Type 2 DiabetesJanuary 14th, 2023
Gut Bacteria Could Be Influential in Development of Type 2 DiabetesJanuary 14th, 2023

Grant Support

Cedars Sinai Clinical Center of the Type 1 Diabetes in Acute Pancreatitis ConsortiumCEDARS-SINAI MEDICAL CENTER2020–2030
Cedars Sinai Center for the Chronic Pancreatitis Clinical Research ConsortiumCEDARS-SINAI MEDICAL CENTER2015–2030
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic riskCEDARS-SINAI MEDICAL CENTER2017–2025